{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:20:30Z","timestamp":1758979230069},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.transproceed.2006.02.125","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T13:37:06Z","timestamp":1151069826000},"page":"1301-1306","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (myfortic) in De Novo Renal Transplant Recipients: Results of a 12-Month Multicenter, Open-Label, Prospective Study"],"prefix":"10.1016","volume":"38","author":[{"given":"B.","family":"Vogt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Antoniadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vitko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2006.02.125_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for the prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2006.02.125_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2006.02.125_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.transproceed.2006.02.125_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2002","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2006.02.125_bib7","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2006.02.125_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.02.125_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.transproceed.2005.01.063","article-title":"Long-term administration of enteric-coated mycophenolate sodium in kidney transplant patients","volume":"37","author":"Salvadori","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.125_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.02.125_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.transproceed.2004.12.048","article-title":"Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium","volume":"37","author":"Budde","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.125_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2006.02.125_bib13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":"Predicting glomerular filtration rate after kidney transplantation","volume":"12","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib14","doi-asserted-by":"crossref","first-page":"521S","DOI":"10.1016\/j.transproceed.2004.01.037","article-title":"Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients","volume":"36","author":"Nashan","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.125_bib15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.transproceed.2004.07.031","article-title":"Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets","volume":"36","author":"Abbud-Filho","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.125_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-2277.2004.tb00394.x","article-title":"Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil","volume":"17","author":"Hardinger","year":"2004","journal-title":"Transpl Int"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2006.02.125_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007890-200407271-01231","article-title":"Safety and tolerability of myfortic\u00ae in combination with steroids and two regimen of Neoral\u00ae in de novo kidney transplant recipients: 6 months interim results. A randomized, multicentre, open, prospective controlled study","volume":"78","author":"Rostaing","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.transproceed.2004.12.020","article-title":"Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients","volume":"37","author":"Massari","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.02.125_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.TP.0000089006.00653.64","article-title":"Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion","volume":"76","author":"Thervet","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.TP.0000153158.91683.34","article-title":"Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion","volume":"79","author":"Stefoni","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00007890-200205151-00002","article-title":"Clinical validation studies of Neoral C2 monitoring","volume":"73","author":"Nashan","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.02.125_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.transproceed.2004.12.106","article-title":"GI-specific patient-reported outcome instruments differentiate between renal transplant patients with or without GI complications","volume":"37","author":"Kleinman","year":"2005","journal-title":"Transplant Proc"},{"issue":"suppl","key":"10.1016\/j.transproceed.2006.02.125_bib23","first-page":"A2156","article-title":"Improved health related quality of life (HRQoL) in renal transplant patients suffering from gastrointestinal (GI) complaints when converted from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS)","volume":"10","author":"Chan","year":"2005","journal-title":"Nephrology"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506002156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506002156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T13:55:50Z","timestamp":1547560550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134506002156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0041134506002156"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.02.125","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}